Both in Pharmaceuticals
Xenon Pharmaceuticals vs Parabilis Medicines
Over the past year XENE returned −33.3% and PBLS returned −17.9%; their daily moves had a correlation of 0.15.
XENE −33.3% PBLS −17.9%Growth of $1, one year, split-adjusted
| Metric | XENE | PBLS |
|---|---|---|
| Price | $39.14 | $30.30 |
| Market cap | $3.79B | $3.74B |
| Today | +2.38% | +3.57% |
| 1 month | +7.0% | +5.0% |
| 6 months | −33.2% | — |
| Year to date | −12.7% | — |
| 1 year | −4.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −45239.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $930.7M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | — |
| Short % of float | 8.1% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).